Mednet Logo
HomePediatric Hematology/OncologyQuestion

At what level of bone marrow disease would you agree to proceed with transplant for a patient with refractory AML?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Taussig Cancer Institute

Most transplant centers will settle on 5% or fewer blasts by morphology or flow cytometry as the cutoff for transplant. Exceptions or leeway is sometimes given for those undergoing myeloablative/full-intensity conditioning, and those with primary refractory disease. MRD typically refers to disease t...

Register or Sign In to see full answer